Abstract
A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee.
David Caborn, Joel Rush, William Lanzer, Dennis Parenti, Christopher Murray and Synvisc 901 Study Group
The Journal of Rheumatology February 2004, 31 (2) 333-343;
David Caborn
Joel Rush
William Lanzer
Dennis Parenti
In this issue
A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee.
David Caborn, Joel Rush, William Lanzer, Dennis Parenti, Christopher Murray, Synvisc 901 Study Group
The Journal of Rheumatology Feb 2004, 31 (2) 333-343;
A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee.
David Caborn, Joel Rush, William Lanzer, Dennis Parenti, Christopher Murray, Synvisc 901 Study Group
The Journal of Rheumatology Feb 2004, 31 (2) 333-343;